| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endothelial Cells | 13 | 2021 | 1048 | 2.870 |
Why?
|
| Endothelium, Vascular | 11 | 2021 | 891 | 2.770 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 6 | 2021 | 36 | 2.220 |
Why?
|
| Receptors, LDL | 3 | 2017 | 109 | 1.520 |
Why?
|
| Carrier Proteins | 7 | 2021 | 2022 | 1.390 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 5 | 2021 | 52 | 1.180 |
Why?
|
| Acute Lung Injury | 2 | 2018 | 92 | 1.170 |
Why?
|
| Neovascularization, Physiologic | 6 | 2014 | 345 | 1.120 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2017 | 1823 | 0.890 |
Why?
|
| Signal Transduction | 17 | 2021 | 11965 | 0.870 |
Why?
|
| Chemokine CXCL12 | 2 | 2014 | 132 | 0.800 |
Why?
|
| Osteocalcin | 1 | 2021 | 87 | 0.800 |
Why?
|
| Capillary Permeability | 2 | 2018 | 114 | 0.790 |
Why?
|
| Hyperglycemia | 2 | 2021 | 333 | 0.760 |
Why?
|
| Procollagen-Proline Dioxygenase | 5 | 2021 | 46 | 0.740 |
Why?
|
| Cell Movement | 9 | 2018 | 2466 | 0.720 |
Why?
|
| Vasculitis | 1 | 2018 | 61 | 0.650 |
Why?
|
| Insulin Resistance | 2 | 2021 | 731 | 0.620 |
Why?
|
| Bone Morphogenetic Protein 4 | 3 | 2012 | 101 | 0.610 |
Why?
|
| Endotoxins | 1 | 2017 | 96 | 0.600 |
Why?
|
| Endocytosis | 4 | 2017 | 225 | 0.590 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 130 | 0.580 |
Why?
|
| Mice, Knockout | 12 | 2021 | 5710 | 0.580 |
Why?
|
| HEK293 Cells | 5 | 2021 | 1489 | 0.580 |
Why?
|
| Lipopolysaccharides | 1 | 2018 | 558 | 0.560 |
Why?
|
| Glucose | 2 | 2021 | 1248 | 0.550 |
Why?
|
| Retinal Neovascularization | 1 | 2015 | 20 | 0.550 |
Why?
|
| PPAR gamma | 1 | 2017 | 229 | 0.550 |
Why?
|
| Retinal Vessels | 1 | 2015 | 85 | 0.520 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 423 | 0.490 |
Why?
|
| Cells, Cultured | 13 | 2021 | 5637 | 0.480 |
Why?
|
| Mitogen-Activated Protein Kinase 10 | 2 | 2014 | 3 | 0.480 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 324 | 0.480 |
Why?
|
| Cardiovascular System | 1 | 2015 | 145 | 0.470 |
Why?
|
| Mitogen-Activated Protein Kinase Phosphatases | 2 | 2014 | 28 | 0.470 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 146 | 0.470 |
Why?
|
| Dual-Specificity Phosphatases | 2 | 2014 | 36 | 0.470 |
Why?
|
| Homeostasis | 1 | 2018 | 950 | 0.450 |
Why?
|
| Bone Morphogenetic Protein Receptors | 2 | 2014 | 32 | 0.440 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 987 | 0.440 |
Why?
|
| Energy Metabolism | 1 | 2018 | 992 | 0.420 |
Why?
|
| Animals | 30 | 2023 | 59536 | 0.400 |
Why?
|
| Myocytes, Cardiac | 5 | 2022 | 764 | 0.400 |
Why?
|
| Zebrafish Proteins | 1 | 2012 | 163 | 0.400 |
Why?
|
| Bone Morphogenetic Proteins | 2 | 2014 | 268 | 0.390 |
Why?
|
| Pneumonia | 1 | 2017 | 751 | 0.390 |
Why?
|
| Aortic Diseases | 1 | 2012 | 206 | 0.360 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 577 | 0.340 |
Why?
|
| Glucose Tolerance Test | 2 | 2021 | 213 | 0.340 |
Why?
|
| Mice, Inbred C57BL | 7 | 2021 | 6942 | 0.330 |
Why?
|
| Transfection | 5 | 2017 | 2944 | 0.330 |
Why?
|
| Inflammation | 3 | 2023 | 2522 | 0.320 |
Why?
|
| Pseudopodia | 1 | 2007 | 30 | 0.320 |
Why?
|
| Muscle, Skeletal | 1 | 2015 | 1270 | 0.320 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2009 | 265 | 0.320 |
Why?
|
| Myosins | 1 | 2007 | 96 | 0.310 |
Why?
|
| Cell Proliferation | 4 | 2019 | 7226 | 0.310 |
Why?
|
| RNA Interference | 4 | 2017 | 1408 | 0.310 |
Why?
|
| Mitogen-Activated Protein Kinase 7 | 2 | 2005 | 84 | 0.310 |
Why?
|
| Mice | 19 | 2023 | 34495 | 0.300 |
Why?
|
| Cattle | 4 | 2014 | 783 | 0.290 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2007 | 196 | 0.280 |
Why?
|
| Lung | 1 | 2017 | 3151 | 0.270 |
Why?
|
| Atherosclerosis | 2 | 2014 | 935 | 0.260 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2007 | 1533 | 0.240 |
Why?
|
| Carnitine O-Acetyltransferase | 1 | 2023 | 6 | 0.240 |
Why?
|
| Membrane Proteins | 1 | 2014 | 2819 | 0.230 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2015 | 376 | 0.230 |
Why?
|
| Oxidation-Reduction | 2 | 2015 | 717 | 0.220 |
Why?
|
| Phenotype | 4 | 2017 | 6295 | 0.220 |
Why?
|
| Smegmamorpha | 1 | 2022 | 4 | 0.220 |
Why?
|
| Apoptosis | 4 | 2017 | 7591 | 0.210 |
Why?
|
| Fatty Acids | 2 | 2022 | 448 | 0.210 |
Why?
|
| Voltage-Dependent Anion Channel 1 | 1 | 2021 | 26 | 0.210 |
Why?
|
| Neovascularization, Pathologic | 2 | 2014 | 1547 | 0.210 |
Why?
|
| Carnitine O-Palmitoyltransferase | 1 | 2021 | 27 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2021 | 2054 | 0.200 |
Why?
|
| Insulin Receptor Substrate Proteins | 1 | 2021 | 132 | 0.200 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 62 | 0.200 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 167 | 0.200 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2003 | 639 | 0.190 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 85 | 0.190 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 84 | 0.190 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 2 | 2012 | 74 | 0.190 |
Why?
|
| Insulin-Secreting Cells | 1 | 2021 | 154 | 0.180 |
Why?
|
| Disease Models, Animal | 5 | 2017 | 7222 | 0.180 |
Why?
|
| Stress, Mechanical | 3 | 2012 | 311 | 0.180 |
Why?
|
| Diet, High-Fat | 2 | 2021 | 241 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2021 | 347 | 0.180 |
Why?
|
| Green Fluorescent Proteins | 1 | 2021 | 694 | 0.170 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 4143 | 0.170 |
Why?
|
| Osteoblasts | 1 | 2021 | 370 | 0.170 |
Why?
|
| Genes, Reporter | 1 | 2021 | 798 | 0.170 |
Why?
|
| Oxygen | 2 | 2015 | 754 | 0.170 |
Why?
|
| Time Factors | 4 | 2017 | 12926 | 0.170 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2015 | 330 | 0.170 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2018 | 46 | 0.160 |
Why?
|
| Cholesterol | 2 | 2023 | 658 | 0.160 |
Why?
|
| Heart | 2 | 2015 | 1223 | 0.160 |
Why?
|
| Gene Expression Regulation | 2 | 2021 | 4053 | 0.160 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2018 | 182 | 0.160 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2021 | 488 | 0.160 |
Why?
|
| Hypoxia | 3 | 2015 | 443 | 0.160 |
Why?
|
| Nuclear Factor 45 Protein | 1 | 2017 | 12 | 0.150 |
Why?
|
| Genotype | 3 | 2015 | 4109 | 0.150 |
Why?
|
| Recombinant Proteins | 3 | 2012 | 2927 | 0.150 |
Why?
|
| Heart Failure | 2 | 2023 | 2516 | 0.150 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 334 | 0.150 |
Why?
|
| CD36 Antigens | 1 | 2017 | 53 | 0.150 |
Why?
|
| NFATC Transcription Factors | 1 | 2017 | 96 | 0.150 |
Why?
|
| Adipokines | 1 | 2017 | 96 | 0.140 |
Why?
|
| Protein Binding | 3 | 2021 | 3438 | 0.140 |
Why?
|
| Blood Glucose | 1 | 2021 | 1244 | 0.140 |
Why?
|
| Leukocytes | 1 | 2018 | 422 | 0.140 |
Why?
|
| Thiazolidinediones | 1 | 2017 | 148 | 0.140 |
Why?
|
| Humans | 18 | 2021 | 261506 | 0.140 |
Why?
|
| Physical Conditioning, Animal | 1 | 2017 | 112 | 0.140 |
Why?
|
| Cell Adhesion | 1 | 2018 | 1008 | 0.140 |
Why?
|
| Mixed Function Oxygenases | 1 | 2015 | 64 | 0.130 |
Why?
|
| Haploinsufficiency | 1 | 2017 | 294 | 0.130 |
Why?
|
| Organ Specificity | 1 | 2017 | 699 | 0.130 |
Why?
|
| Heart Valves | 1 | 2015 | 66 | 0.130 |
Why?
|
| Insulin | 1 | 2021 | 1454 | 0.130 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 1 | 1 | 2015 | 5 | 0.130 |
Why?
|
| Cadherins | 1 | 2018 | 660 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2015 | 142 | 0.130 |
Why?
|
| Receptors, Adrenergic, beta | 1 | 2015 | 97 | 0.130 |
Why?
|
| Transcription, Genetic | 3 | 2017 | 3154 | 0.130 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2015 | 170 | 0.130 |
Why?
|
| Myocardial Ischemia | 2 | 2015 | 435 | 0.130 |
Why?
|
| Organoselenium Compounds | 1 | 2014 | 6 | 0.130 |
Why?
|
| Isoindoles | 1 | 2014 | 11 | 0.130 |
Why?
|
| Cell Hypoxia | 1 | 2015 | 328 | 0.130 |
Why?
|
| Neointima | 1 | 2015 | 53 | 0.130 |
Why?
|
| Oxidative Stress | 3 | 2015 | 1129 | 0.120 |
Why?
|
| SOX9 Transcription Factor | 1 | 2015 | 170 | 0.120 |
Why?
|
| MAP Kinase Signaling System | 1 | 2018 | 848 | 0.120 |
Why?
|
| Azoles | 1 | 2014 | 47 | 0.120 |
Why?
|
| Retinoblastoma Protein | 1 | 2015 | 335 | 0.120 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2015 | 249 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 1077 | 0.120 |
Why?
|
| Weight Gain | 1 | 2017 | 464 | 0.120 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2015 | 198 | 0.120 |
Why?
|
| Acetylcysteine | 1 | 2014 | 143 | 0.110 |
Why?
|
| Models, Anatomic | 1 | 2014 | 154 | 0.110 |
Why?
|
| Models, Cardiovascular | 1 | 2014 | 202 | 0.110 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2015 | 197 | 0.110 |
Why?
|
| Lipids | 1 | 2017 | 644 | 0.110 |
Why?
|
| Phosphorylation | 2 | 2015 | 4804 | 0.110 |
Why?
|
| Calcium-Binding Proteins | 1 | 2015 | 545 | 0.110 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2011 | 1538 | 0.110 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 121 | 0.100 |
Why?
|
| Myocardium | 2 | 2015 | 1313 | 0.100 |
Why?
|
| Isoenzymes | 1 | 2014 | 614 | 0.100 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 164 | 0.100 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 221 | 0.100 |
Why?
|
| Vascular Calcification | 1 | 2012 | 50 | 0.100 |
Why?
|
| Vascular Diseases | 1 | 2014 | 246 | 0.100 |
Why?
|
| Dioxygenases | 1 | 2012 | 159 | 0.100 |
Why?
|
| Apolipoproteins E | 1 | 2012 | 221 | 0.100 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2011 | 60 | 0.100 |
Why?
|
| Cell Line | 3 | 2015 | 5114 | 0.100 |
Why?
|
| Antioxidants | 1 | 2014 | 507 | 0.100 |
Why?
|
| Interleukin-11 | 1 | 2010 | 37 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2005 | 5270 | 0.100 |
Why?
|
| Enzyme Activation | 2 | 2005 | 1764 | 0.100 |
Why?
|
| Hindlimb | 1 | 2010 | 105 | 0.090 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 1362 | 0.090 |
Why?
|
| Aorta | 1 | 2014 | 692 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 1374 | 0.090 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2015 | 973 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2015 | 2084 | 0.090 |
Why?
|
| Coronary Vessels | 1 | 2014 | 665 | 0.090 |
Why?
|
| Zebrafish | 1 | 2012 | 463 | 0.090 |
Why?
|
| Femoral Artery | 1 | 2010 | 210 | 0.090 |
Why?
|
| RNA, Small Interfering | 2 | 2012 | 2216 | 0.090 |
Why?
|
| Gene Expression Regulation, Developmental | 3 | 2014 | 1498 | 0.090 |
Why?
|
| Hydroxylation | 2 | 2021 | 65 | 0.080 |
Why?
|
| Male | 8 | 2023 | 123000 | 0.080 |
Why?
|
| RNA, Messenger | 2 | 2017 | 6150 | 0.080 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2007 | 13 | 0.080 |
Why?
|
| DNA Damage | 2 | 2015 | 1954 | 0.080 |
Why?
|
| Cytokines | 1 | 2017 | 2809 | 0.080 |
Why?
|
| Ischemia | 1 | 2010 | 391 | 0.080 |
Why?
|
| Smad Proteins | 1 | 2007 | 88 | 0.080 |
Why?
|
| Cell Polarity | 1 | 2007 | 208 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2007 | 4078 | 0.070 |
Why?
|
| Models, Biological | 1 | 2014 | 3254 | 0.060 |
Why?
|
| 3',5'-Cyclic-GMP Phosphodiesterases | 1 | 2004 | 44 | 0.060 |
Why?
|
| Animals, Newborn | 2 | 2022 | 1338 | 0.060 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2012 | 1756 | 0.060 |
Why?
|
| Cyclic GMP | 1 | 2004 | 116 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 259 | 0.060 |
Why?
|
| Stem Cells | 2 | 2014 | 1213 | 0.060 |
Why?
|
| bcl-Associated Death Protein | 1 | 2003 | 26 | 0.060 |
Why?
|
| MAP Kinase Kinase 5 | 1 | 2003 | 9 | 0.060 |
Why?
|
| Culture Media, Serum-Free | 1 | 2003 | 74 | 0.060 |
Why?
|
| Rats | 4 | 2015 | 6086 | 0.060 |
Why?
|
| Cycloheximide | 1 | 2003 | 97 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2006 | 397 | 0.060 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 280 | 0.060 |
Why?
|
| Angiotensin II | 1 | 2004 | 198 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5539 | 0.060 |
Why?
|
| Nucleotidyltransferases | 1 | 2023 | 82 | 0.060 |
Why?
|
| Ribosomal Protein S6 Kinases, 90-kDa | 1 | 2003 | 88 | 0.060 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 448 | 0.060 |
Why?
|
| Ubiquitin | 1 | 2005 | 344 | 0.060 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 234 | 0.060 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 741 | 0.050 |
Why?
|
| Caspase 3 | 1 | 2003 | 471 | 0.050 |
Why?
|
| Interferon Type I | 1 | 2023 | 250 | 0.050 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2004 | 703 | 0.050 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 371 | 0.050 |
Why?
|
| Stress, Physiological | 2 | 2015 | 492 | 0.050 |
Why?
|
| United States | 1 | 2018 | 15433 | 0.050 |
Why?
|
| Caspases | 1 | 2003 | 661 | 0.050 |
Why?
|
| Carnitine | 1 | 2021 | 94 | 0.050 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 157 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2021 | 611 | 0.050 |
Why?
|
| Respiration | 1 | 2022 | 447 | 0.040 |
Why?
|
| Lysosomes | 2 | 2015 | 347 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2023 | 677 | 0.040 |
Why?
|
| Cell Survival | 1 | 2003 | 3045 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 2 | 2010 | 272 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2015 | 2063 | 0.030 |
Why?
|
| Thyroid Hormone Receptors alpha | 1 | 2015 | 14 | 0.030 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2019 | 435 | 0.030 |
Why?
|
| Nuclear Receptor Co-Repressor 2 | 1 | 2015 | 47 | 0.030 |
Why?
|
| Carotid Artery Injuries | 1 | 2015 | 40 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 249 | 0.030 |
Why?
|
| Shear Strength | 1 | 2014 | 35 | 0.030 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 2488 | 0.030 |
Why?
|
| Mitochondria | 1 | 2021 | 1282 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor beta | 1 | 2015 | 153 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2015 | 184 | 0.030 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 162 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 2015 | 358 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2006 | 5159 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2015 | 291 | 0.030 |
Why?
|
| Protein Stability | 1 | 2015 | 370 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2015 | 284 | 0.030 |
Why?
|
| Proteolysis | 1 | 2015 | 370 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 664 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2014 | 842 | 0.030 |
Why?
|
| Checkpoint Kinase 1 | 1 | 2012 | 174 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 394 | 0.020 |
Why?
|
| Cell Division | 1 | 2015 | 2489 | 0.020 |
Why?
|
| Ligation | 1 | 2010 | 193 | 0.020 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2012 | 430 | 0.020 |
Why?
|
| Clathrin | 1 | 2009 | 34 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2010 | 593 | 0.020 |
Why?
|
| Hypertension, Pulmonary | 1 | 2014 | 462 | 0.020 |
Why?
|
| HeLa Cells | 1 | 2012 | 1643 | 0.020 |
Why?
|
| Protein Kinases | 1 | 2012 | 874 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2015 | 3005 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 709 | 0.020 |
Why?
|
| Gene Expression | 1 | 2015 | 3570 | 0.020 |
Why?
|
| Base Sequence | 1 | 2012 | 4917 | 0.020 |
Why?
|
| Cyclic Nucleotide Phosphodiesterases, Type 5 | 1 | 2004 | 8 | 0.020 |
Why?
|
| Hypertension | 1 | 2014 | 1503 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 1549 | 0.020 |
Why?
|
| STAT3 Transcription Factor | 1 | 2010 | 1121 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2012 | 2045 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2006 | 668 | 0.010 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2004 | 460 | 0.010 |
Why?
|
| Female | 3 | 2023 | 141928 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2009 | 1682 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2012 | 3552 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2004 | 2450 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2004 | 4757 | 0.010 |
Why?
|